HomeATTBF • OTCMKTS
add
Abattis Bioceuticals Ord Shs
Previous close
$0.00
Day range
$0.00 - $0.00
Avg Volume
46.68K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | 2019info | Y/Y change |
|---|---|---|
Revenue | 356.88K | 4,163.24% |
Operating expense | 4.15M | -73.70% |
Net income | -3.04M | 96.10% |
Net profit margin | -852.40 | 99.91% |
Earnings per share | — | — |
EBITDA | -3.84M | 75.62% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | 2019info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.40M | -73.59% |
Total assets | 19.26M | 68.97% |
Total liabilities | 8.59M | 2,734.79% |
Total equity | 10.67M | — |
Shares outstanding | 476.05M | — |
Price to book | 0.00 | — |
Return on assets | -15.94% | — |
Return on capital | -22.30% | — |
Cash Flow
Net change in cash
| (CAD) | 2019info | Y/Y change |
|---|---|---|
Net income | -3.04M | 96.10% |
Cash from operations | 9.41M | 213.68% |
Cash from investing | -11.52M | 29.06% |
Cash from financing | 60.00K | -99.79% |
Net change in cash | -2.04M | -157.79% |
Free cash flow | -2.46M | 65.86% |
About
Founded
1997
Headquarters
Website
